Presentations

Presentations


Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium


Development of a Novel Prognostic Score

for Relapsed/Refractory Mature T-Cell

and NK-Cell Lymphomas (PIRT):

Results from a Global Peripheral

T-Cell Lymphoma (PETAL) Consortium


Development of a Novel Prognostic Score for Relapsed/Refractory Mature T-Cell and NK-Cell Lymphomas (PIRT): Results from a Global Peripheral T-Cell Lymphoma (PETAL) Consortium


Angela Koh

B. Poster presentations


Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics



Unveiling the Tumor Microenvironment

in Extranodal NK/T-Cell Lymphoma

(ENKTCL) Patients with in Situ Spatial Transcriptomics


Unveiling the Tumor Microenvironment in Extranodal NK/T-Cell Lymphoma (ENKTCL) Patients with in Situ Spatial Transcriptomics



Dimitra Karagkouni


Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas


Real-World Evidence for Duvelisib and Romidepsin Combination in Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas

Josie Ford


Integrative Analysis of 3D Chromatin Organization Revealed Regulation Mechanisms in Angioimmunoblastic T-Cell Lymphoma


Integrative Analysis of 3D Chromatin Organization Revealed Regulation

Mechanisms in Angioimmunoblastic

T-Cell Lymphoma

Makoto Iwasaki


Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (PEripheral T-Cell Lymphoma) Consortium
Presented by Alexandra Lenart

Integrated Omics to Dissect the

Landscape in Chemosensitive and

Refractory Extranodal Natural-Killer

T-Cell Lymphoma (ENKTCL): A Global

Study of the PETAL (PEripheral

T-Cell Lymphoma) Consortium
Presented by Alexandra Lenart


Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (PEripheral T-Cell Lymphoma) Consortium
Presented by Alexandra Lenart

Alexandra Lenart


Real-World Evidence of Duvelisib and Romidepsin Combination
in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas
Presented by Kusha Chopra

Real-World Evidence of Duvelisib and

Romidepsin Combination in Relapsed/

Refractory (R/R) Peripheral and Cutaneous

T-Cell Lymphomas
Presented by Kusha Chopra


Real-World Evidence of Duvelisib and Romidepsin Combination
in Relapsed/Refractory (R/R) Peripheral and Cutaneous T-Cell Lymphomas
Presented by Kusha Chopra

Kusha Chopra


Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma) Consortium, Presented by: Sean M McCabe

Integrated Omics to Dissect the

Landscape in Chemosensitive and

Refractory Extranodal Natural-Killer

T-Cell Lymphoma (ENKTCL): A Global

Study of the PETAL (Peripheral T-Cell

Lymphoma) Consortium, Presented

by: Sean M McCabe


Integrated Omics to Dissect the Landscape in Chemosensitive and Refractory Extranodal Natural-Killer T-Cell Lymphoma (ENKTCL): A Global Study of the PETAL (Peripheral T-Cell Lymphoma) Consortium, Presented by: Sean M McCabe


Integrative analysis of 3D chromatin organization reveals regulation mechanisms in angioimmunoblastic T-cell lymphoma, Presented by: Caroline MacVicar

Integrative analysis of 3D chromatin

organization reveals regulation

mechanisms in angioimmunoblastic

T-cell lymphoma,

Presented by: Caroline MacVicar

Caroline MacVicar


Molecular Residual Disease Detection via CAPP-Seq in Patients with PTCL Undergoing Autologous Stem Cell Transplantation, Presented by: Josie Ford

Molecular Residual Disease Detection

via CAPP-Seq in Patients with PTCL

Undergoing Autologous Stem Cell

Transplantation,

Presented by: Josie Ford


Real-World Evidence for Devlisib and Romidepsin Combination in Patients with Relapsed/Refractory (R/R) Peripheral T-cell Lymphoma, Presented by: Josie Ford

Real-World Evidence for Devlisib and

Romidepsin Combination in Patients

with Relapsed/Refractory (R/R)

Peripheral T-cell Lymphoma,

Presented by: Josie Ford